Loading...

ALK-rearrangements and testing methods in non-small cell lung cancer: a review

The anaplastic lymphoma tyrosine kinase (ALK) gene was first described as a driver mutation in anaplastic non-Hodgkin's lymphoma. Dysregulated ALK expression is now an identified driver mutation in nearly twenty different human malignancies, including 4-9% of non-small cell lung cancers (NSCLC)...

Full description

Saved in:
Bibliographic Details
Main Authors: Shackelford, Rodney E., Vora, Moiz, Mayhall, Kim, Cotelingam, James
Format: Artigo
Language:Inglês
Published: Impact Journals LLC 2014
Subjects:
Online Access:https://ncbi.nlm.nih.gov/pmc/articles/PMC4063252/
https://ncbi.nlm.nih.gov/pubmed/24955213
Tags: Add Tag
No Tags, Be the first to tag this record!